Lilac Syrup 120Ml

Description

LILAC SYRUP 120ML

Description :

Lilac syrup, which contains lactulose with other sugars eg, galactose and lactose, is used in the treatment of constipation and hepatic encephalopathy. Lactulose is a disaccharide, a sugar molecule composed of 2 smaller sugar molecules bonded together, in this case, fructose and galactose. Lactulose is a solid substance that is very soluble in water and has a sweet taste. It is sweeter than lactose but not as sweet as fructose. Chemically, lactulose is also known as 4-O-?-D-galactopyranosyl-D-fructofuranose. The molecular formula is C12H22O11 with a molecular weight of 342.3 daltons.

Indications / Uses :

Relief of constipation including chronic constipation. Portal systemic encephalopathy: Hepatic coma or precoma stages where hyperammonemia is present.

Administration :

May be taken with or without food: May be taken w/ meals to reduce GI discomfort.

Contraindications :

Patients who require a low lactose diet; with galactosemia or disaccharide deficiency; with intestinal obstruction.

Special Precautions :

General: As with all laxatives, extended use may cause dependence for bowel function. No laxative should be taken for >1 week without the advice of a physician. No laxative should be used in the presence of abdominal pain nausea, fever or vomiting, as such symptoms may signal appendicitis or an inflamed bowel.

Lactose Intolerance: Care should be taken in patients who are lactose-intolerant.

Diabetics: Lactulose syrup contains galactose and lactose and should be used with caution in diabetics as blood glucose levels may be elevated, usually after extended use.

Portal Systemic Encephalopathy: In the overall management of portal systemic encephalopathy, it should be recognized that there is a preexisting hepatic disease and efforts should be made to identify and treat the precipitating cause of hepatic coma. Other laxatives should not be used especially during the initial phase of therapy for portal systemic encephalopathy because the loose stools resulting from their use may falsely suggest that adequate dosing has been achieved.

Use in pregnancy: Lilac should be used during pregnancy only if clearly needed under the advice of a medical physician.

Use in lactation: It is not known whether lactulose is excreted in human milk but because most drugs are excreted in human

milk, it should not be given to breastfeeding women unless the benefits to the mother outweigh the potential risks to the feeding infant.

Use in children: It is recommended that if lactulose syrup is given to infants or children for periods >1 month, this should be done under medical supervision.

Use in the elderly: Elderly, debilitated patients who receive lactulose for >6 months should have serum electrolytes (potassium, chloride, carbon dioxide) measured periodically.